# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-021952
Filing Date
2024-05-09
Accepted
2024-05-09 07:07:02
Documents
84
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vnda-20240331.htm iXBRL | 10-Q | 929853
2 | EX-31.1 | vndaex311331202410q.htm | EX-31.1 | 10477
3 | EX-31.2 | vndaex312331202410q.htm | EX-31.2 | 10101
4 | EX-32.1 | vndaex321331202410q.htm | EX-32.1 | 6660
| Complete submission text file | 0001628280-24-021952.txt |  | 5735941

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vnda-20240331.xsd | EX-101.SCH | 49393
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vnda-20240331_cal.xml | EX-101.CAL | 64101
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vnda-20240331_def.xml | EX-101.DEF | 213772
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vnda-20240331_lab.xml | EX-101.LAB | 561505
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vnda-20240331_pre.xml | EX-101.PRE | 408268
88 | EXTRACTED XBRL INSTANCE DOCUMENT | vnda-20240331_htm.xml | XML | 692552

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 24928514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)